These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37266988)
1. Comparison table: Triptans. Med Lett Drugs Ther; 2023 Jun; 65(1678):e97-e99. PubMed ID: 37266988 [No Abstract] [Full Text] [Related]
2. Lasmiditan (Reyvow) and ubrogepant (Ubrelvy) for acute treatment of migraine. Med Lett Drugs Ther; 2020 Mar; 62(1593):35-39. PubMed ID: 32555120 [No Abstract] [Full Text] [Related]
3. Drugs for migraine. Med Lett Drugs Ther; 2023 Jun; 65(1678):89-96. PubMed ID: 37266987 [No Abstract] [Full Text] [Related]
4. Drugs for Migraine. Med Lett Drugs Ther; 2020 Oct; 62(1608):153-160. PubMed ID: 33434187 [No Abstract] [Full Text] [Related]
5. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy. Kelman L; Von Seggern RL Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536 [TBL] [Abstract][Full Text] [Related]
6. Triptans for the management of migraine. Johnston MM; Rapoport AM Drugs; 2010 Aug; 70(12):1505-18. PubMed ID: 20687618 [TBL] [Abstract][Full Text] [Related]
7. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. McCormack PL; Foster RH Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021 [TBL] [Abstract][Full Text] [Related]
8. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen P; De Vries P; Saxena PR Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308 [TBL] [Abstract][Full Text] [Related]
11. The use of triptans for pediatric migraines. Eiland LS; Hunt MO Paediatr Drugs; 2010 Dec; 12(6):379-89. PubMed ID: 21028917 [TBL] [Abstract][Full Text] [Related]
13. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. Dodick DW; Sandrini G; Williams P CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530 [TBL] [Abstract][Full Text] [Related]
16. Comparative aspects of triptans in treating migraine. Adelman JU; Lewit EJ Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316 [TBL] [Abstract][Full Text] [Related]
17. Eletriptan: a review of its use in the acute treatment of migraine. McCormack PL; Keating GM Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799 [TBL] [Abstract][Full Text] [Related]
18. Frovatriptan: a review of its use in the acute treatment of migraine. Sanford M CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951 [TBL] [Abstract][Full Text] [Related]
19. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Ferrari MD; Roon KI; Lipton RB; Goadsby PJ Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541 [TBL] [Abstract][Full Text] [Related]
20. Spotlight on rizatriptan in migraine. Wellington K; Jarvis B CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]